Small Molecule Healthcare Contract Manufacturing Market Trends Analysis Report 2025-2033: Growing Demand for Advanced CMOs Specializing in HPAPIs and Comp…

Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for ...

Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API D…

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Phlow and Enveda Partner to Advance AI-Driven Chemistry to Accelerate Domestic Pharmaceutical Development and Transform Drug Substance Manufacturing

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

Small Molecule API Market Size to Reach USD 328.03 Billion by 2033, Driven by Rising Demand for Cost-Effective Therapeutics – SNS Insider

Strong R&D investment, advanced manufacturing technologies, and supportive government policies accelerate global API production growth.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Small Molecule ...
Morningstar

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
FiercePharma

API Innovation Center looks to bolster US cancer drug supplies with Apertus deal, new tech

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Contract Pharma

Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
NJBIZ

Cambrex to invest $120M to expand U.S. drug production

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
Business Wire

Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm

BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from ...
Business Wire

Avista Pharma Solutions Doubles API Manufacturing Capacity at Colorado Facility

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...
FiercePharma

FDA wallops Indian drugmaker with warning letter blasting API quality, equipment cleanliness and more

What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...
Nasdaq

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...